eTARGET
Click HereClick Here
Previous
Next
eTARGET supporting Molecular Tumour Boards
- DHP Purpose – Interpretation
- Licence – MIT /GLP 3.0
- Maturity – Multi Centre
eTARGET has overcome the challenge of integrating data from disparate sources in different organisations.
It presents a single view of patient clinical and genomic NGS data to support decision making for an MTB.
Key Features
Clinical
Integrates clinical and genomic data to support decision making by Molecular Tumour Boards. Developed by the Manchester Cancer Research Centre as part of the TARGET trial (Tumour chARacterisation to Guide Experimental Targeted therapy)
Data
Integrates clinical, tumour NGS and circulating tumour DNA NGS data
Technical
eTARGET is a web solution deployed within Microsoft Azure
